Digitisation | April 17, 2026
OpenAI unveils GPT-Rosalind to accelerate drug discovery for pharma giants
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
At launch of updated pediatric gastroenterology textbook, Union Minister says technology must strengthen not substitute core medical learning
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology
Three-year CSR partnership to scale community-led mental healthcare access across Chhindwara district
AI-enabled women’s digital clinic brings in-person consultations to complement app-led care after serving over 400,000 women across India
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
Subscribe To Our Newsletter & Stay Updated
